Vitan-Biotech LLC
- UEI
- ML5NLF9L1FP9
- CAGE
- 5SXC2
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Field-deployable, low-cost point-of-need urine test strips for mobile quantification of SUD medication drugs and their… | National Institute on Drug Abuse | $586,936 | |
| Developing an integrated pipeline for routine generation of orthogonal gpcr-targeting nanobodies - project summary a… | National Institute of General Medical Sciences | $218,622 | |
| Plasmonic glycan arrays for highly sensitive detection of glycan-binding proteins | National Institute of General Medical Sciences | $222,939 | |
| Development of safe and effective immunotherapeutics for treatment of opioid abuse and overdose | National Institute on Drug Abuse | $224,938 | |
| Developing high-affinity nanobodies to tumor-associated glycan antigens | National Institute of General Medical Sciences | $149,937 |
About Vitan-Biotech LLC
Vitan-Biotech LLC is a minority-owned, for-profit biotechnology company based in Aurora, Colorado, specializing in innovative medical diagnostic and research technologies. Registered in SAM.gov since 2009, the company focuses on developing advanced biomedical solutions with an emphasis on point-of-care diagnostics, molecular research tools, and specialized testing technologies for complex medical challenges.
The company has secured multiple competitive federal grants from prestigious agencies like the National Institute on Drug Abuse (NIDA) and the National Institute of General Medical Sciences (NIGMS), predominantly through Small Business Innovation Research (SBIR) mechanisms. Recent federal grant awards demonstrate Vitan-Biotech's expertise in developing sophisticated diagnostic technologies, including a $586,936 grant to create a low-cost, disposable urine test strip for quantifying substance use disorder medication drugs, and a $218,622 grant to develop an integrated pipeline for discovering nanobodies targeting G protein-coupled receptors relevant to neurological disorders. Their research focuses on innovative approaches such as creating lateral flow assays with signal amplification, cell-free membrane protein synthesis, and advanced molecular detection methods. These projects aim to generate novel diagnostic tools, research reagents, and technologies that could potentially improve medical diagnostics, drug monitoring, and understanding of complex neurological conditions. The company's work spans multiple scientific domains, including addiction treatment monitoring, receptor research, and advanced diagnostic technology development.
Quick answers
What is Vitan-Biotech LLC's UEI?
Vitan-Biotech LLC's Unique Entity ID (UEI) in SAM.gov is ML5NLF9L1FP9.
What is Vitan-Biotech LLC's CAGE code?
Vitan-Biotech LLC's CAGE code is 5SXC2.
What is Vitan-Biotech LLC's primary NAICS code?
Vitan-Biotech LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Is Vitan-Biotech LLC registered in SAM.gov?
Vitan-Biotech LLC's SAM.gov registration expired on September 3, 2026.
What is Vitan-Biotech LLC's most recent federal award?
Vitan-Biotech LLC's most recent federal grant award is Field-deployable, low-cost point-of-need urine test strips for mobile quantification of SUD medication drugs and their… (R43DA061396), from National Institute on Drug Abuse, on August 1, 2024.
On GovTribe
See Vitan-Biotech LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors